Return to content in this issue


Use of concentrated plasma-derived subcutaneous C1 inhibitor as long-term prophylaxis in an 8-year-old child with hereditary angioedema

Lasa EM1, Herrero L2, Martínez S1, Arruti N1, Oliver P2, Joral A1

1Hospital Universitario de Donostia, San Sebastián, Spain
2Hospital de Mendaro, Mendaro, Spain

J Investig Allergol Clin Immunol 2023; Vol. 33(4)
doi: 10.18176/jiaci.0855

Key words: C inhibitor deficiency, Hereditary angioedema, Children, Long-term treatment, Management